Tutorials
Legend Biotech Corp logo

Legend Biotech Corp

$ 46.98 +0.89 (+1.93%) 08:09 PM EST
P/E:
At Loss
P/B:
16.58
Market Cap:
$ 7.27B
Enterprise V:
$ 6.61B
Volume:
521.34K
Avg Vol (2M):
812.93K
Also Trade In:
Volume:
521.34K
Market Cap $:
7.27B
PE Ratio:
At Loss
Avg Vol (2-Month):
812.93K
Enterprise Value $:
6.61B
PB Ratio:
16.58
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Legend Biotech Corp
NAICS : 541714 SIC : 2834
2101 Cottontail Lane, Somerset, NJ, USA, 08873
Description
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from North America.
Name Current Vs Industry Vs History
Cash-To-Debt 6.12
Equity-to-Asset 0.42
Debt-to-Equity 0.3
Debt-to-EBITDA -0.39
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7
Distress
Grey
Safe
Beneish M-Score -2.8
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 9.1
3-Year EPS without NRI Growth Rate -399.4
3-Year Book Growth Rate 228.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 40.68
9-Day RSI 43.31
14-Day RSI 45.21
6-1 Month Momentum % 36.52
12-1 Month Momentum % 38.02

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.83
Quick Ratio 3.81
Cash Ratio 3.51
Days Sales Outstanding 106.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.5

Financials (Next Earnings Date:2022-08-23 Est.)

LEGN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:LEGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 116.937
EPS (TTM) ($) -2.4
Beta 0
Volatility % 53.78
14-Day RSI 45.21
14-Day ATR ($) 2.53919
20-Day SMA ($) 48.356
12-1 Month Momentum % 38.02
52-Week Range ($) 30.755 - 58
Shares Outstanding (Mil) 154.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Legend Biotech Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More